• About us
    • Scandion Oncology
    • Board of Directors
    • Management
    • Scientific Advisory Board
    • Business idea
  • Research
    • Research and Technology
    • Pipeline
    • Clinical trials
    • Publications
  • Latest news
  • Press releases
  • Investors
    • Overview
    • Share information
    • Rights Issue 2020
    • Rights Issue 2019
    • Subscription Warrant (SCOL TO 1)
    • Presentations & Media coverage
    • Reports
    • Financial calendar
    • Corporate governance
    • Patents
  • Contact
  • About us
    • Scandion Oncology
    • Board of Directors
    • Management
    • Scientific Advisory Board
    • Business idea
  • Research
    • Research and Technology
    • Pipeline
    • Clinical trials
    • Publications
  • Latest news
  • Press releases
  • Investors
    • Overview
    • Share information
    • Rights Issue 2020
    • Rights Issue 2019
    • Subscription Warrant (SCOL TO 1)
    • Presentations & Media coverage
    • Reports
    • Financial calendar
    • Corporate governance
    • Patents
  • Contact

Invest Talks

Read the interview (in Swedish) with CEO Bo Rode Hansen featured in today’s “Invest Talks – Sektoranalys Health Care in Dagens Industri” here.

Latest news & press releases
24.Mar 21

CSO Nils Brünner will retire from Scandion Oncology A/S
Scandion Oncology A/S has agreed with Nils Brünner that he will leave his pos...

24.Mar 21

Scandion Oncology is recruiting a Financial Controller
Be our new Financial Controller in a biotech company focused on develop...

19.Mar 21

Scandion Oncology appoints Dr. Maj Hedtjärn as COO and Head of R&D Operations
Scandion Oncology appoints Dr. Maj Hedtjärn as COO and Head of R&D Operations...

Scandion Oncology A/S

Symbion
Fruebjergvej 3
DK – 2100 Copenhagen
Denmark

Social media

Linkedin
Twitter

Press

Bo Rode Hansen, President & CEO
E: info@scandiononcology.com
P: +45 38 10 20 17

Stay updated with our newsletter

Get notified on mail, when news or press release is posted on our website.

Privacy and Cookie Policy